Bio-Techne Corp.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $643.0M | $563.0M | $499.0M | $452.2M | $357.8M | $310.6M | $314.6M | $290.0M |
| Biotechnology | $0 | $0 | $317.3M | — | — | — | — | — |
| Clinical Controls | $0 | $0 | $104.5M | — | — | — | — | — |
| Protein Platforms | $0 | $0 | $77.3M | — | — | — | — | — |
| Protein Sciences | $482.4M | $419.4M | $0 | — | — | — | — | — |
| Diagnostics and Genomics | $161.2M | $143.7M | $0 | — | — | — | — | — |
| Diagnostics and Spatial Biology | $0 | $0 | $0 | — | — | — | — | — |
| Other | $0 | $0 | $0 | — | — | — | — | — |
| Eliminations | $-536.0K | $-104.0K | $-125.0K | — | — | — | — | — |
| Cost of Revenue | $210.9M | $188.5M | $162.4M | $145.0M | $106.4M | $79.5M | $78.8M | $65.0M |
| Gross Profit | $432.1M | $374.5M | $336.7M | $307.3M | $251.4M | $231.1M | $235.8M | $224.9M |
| Gross Margin | 67.2% | 66.5% | 67.5% | 67.9% | 70.3% | 74.4% | 75.0% | 77.6% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $240.6M | $200.4M | $140.9M | $119.4M | $60.7M | $43.4M | $41.7M | $35.9M |
| Operating Income | $136.2M | $120.6M | $150.6M | $147.0M | $159.8M | $158.5K | $166.2M | $163.1M |
| Operating Margin | 21.2% | 21.4% | 30.2% | 32.5% | 44.7% | 0.1% | 52.8% | 56.2% |
| Interest Expense | $10.2M | $7.4M | $1.7M | $1.5M | $0 | $0 | — | — |
| Pretax Income | $126.0M | $112.0M | $147.5M | $154.2M | $161.4M | $160.7M | $162.2M | $165.0M |
| Income Tax Expense | $-198.0K | $35.9M | $43.0M | $46.4M | $50.4M | $48.1M | $49.9M | $52.7M |
| Net Income | $126.2M | $76.1M | $104.5M | $107.7M | $110.9M | $112.6M | $112.3M | $112.3M |
| Net Margin | 19.6% | 13.5% | 20.9% | 23.8% | 31.0% | 36.2% | 35.7% | 38.7% |
| EPS (Basic) | $0.84 | $0.51 | $0.70 | $0.73 | $0.75 | $0.77 | $0.76 | $0.76 |
| EPS (Diluted) | $0.83 | $0.51 | $0.70 | $0.72 | $0.75 | $0.76 | $0.76 | $0.76 |
| Shares Outstanding (Basic) | 149.9M | 149.3M | 148.8M | 148.4M | 147.6M | 147.3M | 147.8M | 148.4M |
| Shares Outstanding (Diluted) | 152.2M | 150.0M | 149.3M | 148.9M | 148.0M | 147.6M | 148.0M | 148.7M |
| Dividends Per Share | $0.32 | $0.32 | $0.32 | $0.32 | $0.31 | $0.30 | $0.28 | $0.27 |